Utah Hematology Oncology PC has joined CancerLinQ™, a "big data" initiative developed and led by the American Society of Clinical Oncology (ASCO) to rapidly improve the quality of care for people with cancer. Utah Hematology Oncology PC is one of more than 100 organizations that have signed agreements with a CancerLinQ LLC, a wholly owned nonprofit subsidiary of ASCO dedicated to the development and operation of the CancerLinQ™ system.
CancerLinQ™ will allow cancer care providers to improve the quality and value of care by analyzing millions of cancer patient medical records, uncovering patterns and trends, and measuring their care against that of their peers and recommended guidelines. The CancerLinQ™ platform is the only effort of its kind being driven by a non-profit, physician organization, and it leverages the combined expertise of 40,000 of the world’s leading oncologists who comprise ASCO’s membership and merges it with market-leading big data analytics from SAP. The platform uses SAP Connected Health built on the SAP HANA® platform, a flexible, multi-purpose data management and application platform created by SAP.
“We are thrilled that Utah Hematology Oncology PC has joined CancerLinQ and our mission to improve the care of millions of people living with cancer,” said CancerLinQ LLC Chief Executive Officer Kevin Fitzpatrick. “Each practice that joins CancerLinQ adds to our collective experience and knowledge of cancer care and better equips oncologists to provide higher-quality and more tailored care for patients, no matter where they live.”
CancerLinQ™ is supported in part by the Conquer Cancer Foundation, whose generous donors have helped make the system possible. CancerLinQ™ is a project of CancerLinQ LLC. For more information, please visit CancerLinQ.org.
Founded in 1964, the American Society of Clinical Oncology, Inc. (ASCO®) is committed to making a world of difference in cancer care. As the world’s leading organization of its kind, ASCO represents more than 40,000 oncology professionals who care for people living with cancer. Through research, education, and promotion of the highest-quality patient care, ASCO works to conquer cancer and create
About CancerLinQ LLC
CancerLinQ LLC is a subsidiary of American Society of Clinical Oncology, Inc. established for the development and operation of the CancerLinQ™ initiative. CancerLinQ™ is a health information technology platform aimed at enhancing and improving the understanding and treatment of cancer. To learn more, visit www.cancerlinq.org or enjoy this short video: